-
2 Healthcare REITs Stifel Is Buying On Valuation
Wednesday, August 26, 2015 - 12:14pm | 351Read More...Stifel analyst Daniel Bernstein believes the recent market dip has created some big value for two healthcare REITs. In a new report, Stifel upgrades Healthcare Realty Trust Inc (NYSE: HR) and Healthcare Trust of America (NYSE: HTA) to Buy. MOB REITs The two REITs that Bernstein focuses on in...
-
Why Stifel Likes This 6% Yielding Small-Cap Healthcare REIT
Wednesday, July 1, 2015 - 10:55am | 743Read More...Last week, Stifel analysts Chad Vanacore and Daniel Bernstein published a research note titled, "Sabra Makes for a Compelling Value Play." Prior to the report, Sabra Health Care REIT Inc (NASDAQ: SBRA) just completed a 5.9 million share secondary offering at $25.25 per share, raising ~$149 million...
-
Stifel, JMP Securities Review Omega Healthcare Following Mixed Earnings
Wednesday, February 25, 2015 - 2:03pm | 249Read More...Stifel and JMP Securities on Wednesday issued a report on Omega Healthcare Investors Inc (NYSE: OHI) after the company reported fourth-quarter earnings that were mixed. While Omega Healthcare's revenue of $131.30 million beat the consensus estimate of $101.12 million, its EPS of $0.68...
-
UPDATE: Stifel Downgrades BioMed Realty Trust On Valuation
Monday, February 9, 2015 - 9:33am | 110Read More...In a report published Monday, Stifel analyst Daniel Bernstein downgraded the rating on BioMed Realty Trust (NYSE: BMR) from Buy to Hold, and removed the $23.00 price target. In the report, Stifel noted, "Shares reached our $23 target, which we see as fair value. While we don't see any major flaw in...
